These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 10586845)

  • 1. Alendronate.
    Hamdy RC
    South Med J; 1999 Nov; 92(11):1118-20. PubMed ID: 10586845
    [No Abstract]   [Full Text] [Related]  

  • 2. [Osteoporotic fracture in menopausal women: alendronate reduces the risk].
    Bize R; Lamy O; Peytremann-Bridevaux I
    Rev Med Suisse; 2008 Dec; 4(183):2703. PubMed ID: 19157286
    [No Abstract]   [Full Text] [Related]  

  • 3. [Osteoporosis compounds in general practice. That is REAL: in routine practice the better choice].
    MMW Fortschr Med; 2007 Mar; 149(13):50. PubMed ID: 17672400
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of parathyroid hormone and alendronate alone or in combination in osteoporosis.
    Miller PD
    N Engl J Med; 2004 Jan; 350(2):189-92; author reply 189-92. PubMed ID: 14714279
    [No Abstract]   [Full Text] [Related]  

  • 5. Alendronate in postmenopausal osteoporosis.
    Liedholm H; Linné AB
    N Engl J Med; 1996 Mar; 334(11):733-4; author reply 734-5. PubMed ID: 8594442
    [No Abstract]   [Full Text] [Related]  

  • 6. Bisphosphonates in the treatment of osteoporosis. Principles and efficacy.
    Papapoulos SE
    Ann Med Interne (Paris); 2000 Oct; 151(6):504-10. PubMed ID: 11104931
    [No Abstract]   [Full Text] [Related]  

  • 7. Health-economic comparison of three recommended drugs for the treatment of osteoporosis.
    Brecht JG; Kruse HP; Möhrke W; Oestreich A; Huppertz E
    Int J Clin Pharmacol Res; 2004; 24(1):1-10. PubMed ID: 15575171
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Universal bone densitometry screening combined with alendronate therapy for those diagnosed with osteoporosis is highly cost-effective for elderly women.
    Schousboe JT; Ensrud KE; Nyman JA; Melton LJ; Kane RL
    J Am Geriatr Soc; 2005 Oct; 53(10):1697-704. PubMed ID: 16181168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Postmenopausal osteoporosis and alendronate.
    Pérez-López FR
    Maturitas; 2004 Jul; 48(3):179-92. PubMed ID: 15207883
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estimating probability of non-response to treatment using mixture distributions.
    Pavlic M; Brand RJ; Cummings SR
    Stat Med; 2001 Jun; 20(12):1739-53. PubMed ID: 11406838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Osteoporosis therapy compared. More solid bones with bisphosphonates].
    MMW Fortschr Med; 2003 Aug; 145(31-32):55. PubMed ID: 14524081
    [No Abstract]   [Full Text] [Related]  

  • 12. [Austrian guidance for the pharmacological treatment of osteoporosis in postmenopausal women--update 2009].
    Dimai HP; Pietschmann P; Resch H; Preisinger E; Fahrleitner-Pammer A; Dobnig H; Klaushofer K;
    Wien Med Wochenschr Suppl; 2009; (122):1-34. PubMed ID: 19484202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Meds hiatus won't hurt your hips. Five years on, five years off: taking a break from Fosamax won't result in broken bones.
    Duke Med Health News; 2007 Apr; 13(4):5. PubMed ID: 17441274
    [No Abstract]   [Full Text] [Related]  

  • 14. Decimal point--osteoporosis therapy at the 10-year mark.
    Strewler GJ
    N Engl J Med; 2004 Mar; 350(12):1172-4. PubMed ID: 15028820
    [No Abstract]   [Full Text] [Related]  

  • 15. Efficacy and safety of alendronate and risedronate for postmenopausal osteoporosis.
    Iwamoto J; Takeda T; Sato Y
    Curr Med Res Opin; 2006 May; 22(5):919-28. PubMed ID: 16709313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ten years of alendronate treatment for osteoporosis in postmenopausal women.
    Ott SM
    N Engl J Med; 2004 Jul; 351(2):190-2; author reply 190-2. PubMed ID: 15250064
    [No Abstract]   [Full Text] [Related]  

  • 17. A comprehensive review of treatments for postmenopausal osteoporosis.
    Häuselmann HJ; Rizzoli R
    Osteoporos Int; 2003 Jan; 14(1):2-12. PubMed ID: 12577179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alendronate produces greater effects than raloxifene on bone density and bone turnover in postmenopausal women with low bone density: results of EFFECT (Efficacy of FOSAMAX versus EVISTA Comparison Trial) International.
    Sambrook PN; Geusens P; Ribot C; Solimano JA; Ferrer-Barriendos J; Gaines K; Verbruggen N; Melton ME
    J Intern Med; 2004 Apr; 255(4):503-11. PubMed ID: 15049885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alendronate in the treatment of postmenopausal osteoporosis.
    Hosking DJ; Favus M; Yates AJ
    Int J Clin Pract Suppl; 1999 Apr; 101():27-35. PubMed ID: 12669738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [To increase bone density faster and stronger].
    MMW Fortschr Med; 2005 May; 147(18):44-5. PubMed ID: 15934589
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.